BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bruno A, Dolcetti E, Rizzo FR, Fresegna D, Musella A, Gentile A, De Vito F, Caioli S, Guadalupi L, Bullitta S, Vanni V, Balletta S, Sanna K, Buttari F, Stampanoni Bassi M, Centonze D, Mandolesi G. Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis. Front Cell Neurosci 2020;14:169. [PMID: 32655374 DOI: 10.3389/fncel.2020.00169] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Benedetti F, Zanardi R, Mazza MG. Antidepressant psychopharmacology: is inflammation a future target? International Clinical Psychopharmacology 2022;37:79-81. [DOI: 10.1097/yic.0000000000000403] [Reference Citation Analysis]
2 Lopresti P. Serum-Based Biomarkers in Neurodegeneration and Multiple Sclerosis. Biomedicines 2022;10:1077. [DOI: 10.3390/biomedicines10051077] [Reference Citation Analysis]
3 Noguera-navarro C, Navas-carrillo D, Orenes-piñero E. Gut microbiota alterations and nutritional intervention in multiple sclerosis disease. Food Reviews International. [DOI: 10.1080/87559129.2022.2062771] [Reference Citation Analysis]
4 Sørensen NV, Orlovska-waast S, Jeppesen R, Christensen RH, Benros ME. Neuroimmunological investigations of cerebrospinal fluid in patients with recent onset depression – a study protocol. BMC Psychiatry 2022;22. [DOI: 10.1186/s12888-021-03633-0] [Reference Citation Analysis]
5 Jiang L, Shen Z, Cheng Y, Lu J, He B, Xu J, Jiang H, Liu F, Li N, Lu Y, Li L, Xu X. Elevated serum neurofilament levels in young first-episode and medication-naïve major depressive disorder patients with alterative white matter integrity. Psychiatry Res Neuroimaging 2021;317:111351. [PMID: 34403967 DOI: 10.1016/j.pscychresns.2021.111351] [Reference Citation Analysis]
6 Stamoula E, Siafis S, Dardalas I, Ainatzoglou A, Matsas A, Athanasiadis T, Sardeli C, Stamoulas K, Papazisis G. Antidepressants on Multiple Sclerosis: A Review of In Vitro and In Vivo Models. Front Immunol 2021;12:677879. [PMID: 34093579 DOI: 10.3389/fimmu.2021.677879] [Reference Citation Analysis]
7 Brasanac J, Ramien C, Gamradt S, Taenzer A, Glau L, Ritter K, Patas K, Agorastos A, Wiedemann K, Demiralay C, Fischer F, Otte C, Bellmann-Strobl J, Friese MA, Tolosa E, Paul F, Heesen C, Weygandt M, Gold SM. Immune signature of multiple sclerosis-associated depression. Brain Behav Immun 2021;100:174-82. [PMID: 34863857 DOI: 10.1016/j.bbi.2021.11.022] [Reference Citation Analysis]
8 Menculini G, Chipi E, Paolini Paoletti F, Gaetani L, Nigro P, Simoni S, Mancini A, Tambasco N, Di Filippo M, Tortorella A, Parnetti L. Insights into the Pathophysiology of Psychiatric Symptoms in Central Nervous System Disorders: Implications for Early and Differential Diagnosis. Int J Mol Sci 2021;22:4440. [PMID: 33922780 DOI: 10.3390/ijms22094440] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Rotolo RA, Demuro J, Drummond G, Little C, Johns LD, Betz AJ. Prophylactic exposure to oral riluzole reduces the clinical severity and immune-related biomarkers of experimental autoimmune encephalomyelitis. J Neuroimmunol 2021;356:577603. [PMID: 33992861 DOI: 10.1016/j.jneuroim.2021.577603] [Reference Citation Analysis]